Peter D. Le

Array ( [id] => 6289943 [patent_doc_number] => 20020055106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Method for generating hypermutable organisms' [patent_app_type] => new [patent_app_number] => 09/853646 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11800 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055106.pdf [firstpage_image] =>[orig_patent_app_number] => 09853646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1329600 [patent_doc_number] => 06596270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Methods of administering adenoviral vectors' [patent_app_type] => B2 [patent_app_number] => 09/835683 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6864 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596270.pdf [firstpage_image] =>[orig_patent_app_number] => 09835683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486351 [patent_doc_number] => 20020152490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Tolerance-inducing thy-marrow composite tissue construct and organ' [patent_app_type] => new [patent_app_number] => 09/834090 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4970 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20020152490.pdf [firstpage_image] =>[orig_patent_app_number] => 09834090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898925 [patent_doc_number] => 20010047090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'VANILREP1 polynucleotides and VANILREP1 polypeptides' [patent_app_type] => new [patent_app_number] => 09/824258 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10270 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20010047090.pdf [firstpage_image] =>[orig_patent_app_number] => 09824258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164476 [patent_doc_number] => 06756201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-29 [patent_title] => 'Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1' [patent_app_type] => B2 [patent_app_number] => 09/795380 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9459 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756201.pdf [firstpage_image] =>[orig_patent_app_number] => 09795380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847072 [patent_doc_number] => 20030166239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Mammalian osteoregulins' [patent_app_type] => new [patent_app_number] => 09/794422 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 29589 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166239.pdf [firstpage_image] =>[orig_patent_app_number] => 09794422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005445 [patent_doc_number] => 06906041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Treatment of immune diseases' [patent_app_type] => utility [patent_app_number] => 09/788552 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9023 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906041.pdf [firstpage_image] =>[orig_patent_app_number] => 09788552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986622 [patent_doc_number] => 20010036454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Genetic modification of the lung as a portal for gene delivery' [patent_app_type] => new [patent_app_number] => 09/784563 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11023 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036454.pdf [firstpage_image] =>[orig_patent_app_number] => 09784563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6283641 [patent_doc_number] => 20020108129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method for producing anterior ischemic optic neuropathy in animals' [patent_app_type] => new [patent_app_number] => 09/727603 [patent_app_country] => US [patent_app_date] => 2001-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1339 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20020108129.pdf [firstpage_image] =>[orig_patent_app_number] => 09727603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629001 [patent_doc_number] => 20020086426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Tetracycline-regulated transcriptional activator fusion proteins' [patent_app_type] => new [patent_app_number] => 09/777317 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 25975 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086426.pdf [firstpage_image] =>[orig_patent_app_number] => 09777317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6176280 [patent_doc_number] => 20020155564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Cloning of a high growth gene' [patent_app_type] => new [patent_app_number] => 09/771208 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37159 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155564.pdf [firstpage_image] =>[orig_patent_app_number] => 09771208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1230395 [patent_doc_number] => 06692738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Delivery of therapeutic biologicals from implantable tissue matrices' [patent_app_type] => B2 [patent_app_number] => 09/770339 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 12706 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692738.pdf [firstpage_image] =>[orig_patent_app_number] => 09770339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622166 [patent_doc_number] => 20020065237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 09/767770 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9338 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065237.pdf [firstpage_image] =>[orig_patent_app_number] => 09767770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736714 [patent_doc_number] => 07033782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => utility [patent_app_number] => 09/760897 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 101 [patent_no_of_words] => 50405 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033782.pdf [firstpage_image] =>[orig_patent_app_number] => 09760897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6894586 [patent_doc_number] => 20010016952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'Pathogenesis of cardiomyopathy' [patent_app_type] => new [patent_app_number] => 09/754765 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13698 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016952.pdf [firstpage_image] =>[orig_patent_app_number] => 09754765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740760 [patent_doc_number] => 20030158129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells' [patent_app_type] => new [patent_app_number] => 09/731289 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6733 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158129.pdf [firstpage_image] =>[orig_patent_app_number] => 09731289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 731430 [patent_doc_number] => 07037492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Gene transfer for studying and treating a connective tissue of a mammalian host' [patent_app_type] => utility [patent_app_number] => 09/731175 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 33 [patent_no_of_words] => 26921 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037492.pdf [firstpage_image] =>[orig_patent_app_number] => 09731175 [rel_patent_id] =>[rel_patent_doc_number] =>)